Chris Gibson | Chief Executive Officer and Co Founder
Recursion Pharmaceuticals

Chris Gibson, Chief Executive Officer and Co Founder, Recursion Pharmaceuticals


BioData West: Day 1 @ 11:20

Augmenting Drug Discovery with Artificial Intelligence at Massive Scale

  • Bringing substantial improvements to the efficiency of discovery and development efforts through the expansion and acceleration of traditional approaches
  • How Recursion views the use of AI in discovery and development – from strategies to accelerate discovery and imaged-based phenotypic screening platforms 
  • Overviews of internal successes in rare disease, immunology, and immuno-oncology  alongside partnerships with large pharmaceutical companies including Sanofi and Takeda
  • Recursion’s 5-7 year vision to leverage technology and massive proprietary datasets to build a map of human cellular biology 

back to speakers